Keloid Disease Can Be Inhibited by Antagonizing Excessive mTOR Signaling With a Novel Dual TORC1/2 Inhibitor
Author:
Publisher
Elsevier BV
Subject
Pathology and Forensic Medicine
Reference81 articles.
1. mTOR signaling;Watanabe;J Nucl Med,2011
2. Blocking the mTOR pathway: a drug discovery perspective;Garcia-Echeverria;Biochem Soc Trans,2011
3. Current and future directions in mammalian target of rapamycin inhibitors development;Fasolo;Exp Opin Invest Drugs,2011
4. The role of autophagy in cytotoxicity induced by new oncogenic B-Raf inhibitor UI-152 in v-Ha-ras transformed fibroblasts;Ahn;Biochem Biophys Res Commun,2011
5. Defining the role of mTOR in cancer;Guertin;Cancer Cell,2007
Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Subcellular Fractionation and Metaproteogenomic Identification and Validation of Key Differentially Expressed Molecular Targets for Keloid Disease;Journal of Investigative Dermatology;2024-08
2. The Novel Cytokine Interleukin-41/Meteorin-like Is Reduced in Diffuse Systemic Sclerosis;Cells;2024-07-17
3. Unraveling DDIT4 in the VDR-mTOR pathway: a novel target for drug discovery in diabetic kidney disease;Frontiers in Pharmacology;2024-03-19
4. Recent Advances in Scar Research and Unanswered Questions;Scars;2024
5. Identification of a potential bioinformatics-based biomarker in keloids and its correlation with immune infiltration;European Journal of Medical Research;2023-11-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3